4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001415889-24-024795
Director sold 40,000 shares at an average $14.73 ($589,101)
- Director acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LYONS GARY A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $10.48 | $419,200 | 91,000 | D |
| 2024-10-04 | Sale : show line 2 in the form 10b5-1 | −21,179 | $14.35 | $303,874 | 69,821 | D |
| 2024-10-04 | Sale : show line 3 in the form 10b5-1 | −18,821 | $15.15 | $285,227 | 51,000 | D |
| Open-market sales · 40,000 sh · avg $14.73 · $589,101 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-04 | Exercise or conversion : show line 4 in the form 10b5-1 Stock option (right to buy) | +40,000 | 0 | D |
Loading xslF345X05/form4-10042024_111048.xml…